Abstract:Sarcopenia, a disease recognized by the World Health Organization, has posed a great challenge to the world in the current aging society. The vital role of the gut microbiome through the gut-muscle axis in sarcopenia is increasingly recognized. However, the working mechanisms by which the gut microbiota functions have not been fully explored in the multi-omics field. Here, we designed a cross-sectional study that recruited patients ( n = 32) with sarcopenia and healthy old adults ( n = 31). Diagnosis of sarcopenia was based on the Asian Working Group for Sarcopenia (AWGS) in 2019 criteria. Muscle mass was represented by appendicular skeletal muscle mass measured by using direct segmental multi-frequency bioelectrical impedance and muscle strength was evaluated using the handgrip strength. The Short Physical Performance Battery, the 5-time Chair Stand Test, and the 4-metre Walk Test were used to assess physical performance. Shotgun metagenomic sequencing was used to profile the gut microbiome in order to identify its construction and function. Metabolome based on untargeted metabolomics was applied to describe the features and structure of fecal metabolites. In clinical indexes including triglycerides and high-density lipoprotein cholesterol, we noted a significant decrease in triglycerides (TG) and a significant increase in high-density lipoprotein cholesterol (HDL-C) in patients with sarcopenia. Appendicular skeletal muscle mass of patients with sarcopenia was lower than the health group. Based on intestinal metagenomic and fecal metabolomic profiles, we found that the gut microbiome and metabolome were disturbed in patients with sarcopenia, with significant decreases in bacteria such as Bifidobacterium longum , Bifidobacterium pseudocatenulatum , and Bifidobacterium adolescentis , as well as metabolites such as shikimic acid. Also, we plotted supervised classification models at the species level of gut bacteria (AUC = 70.83–88.33) and metabolites (AUC = 92.23–98.33) based on machine learning, respectively. Based on the gut-muscle axis network, a potential mechanism is proposed along the gut microbiome - key metabolites - clinical index, that Phascolarctobacterium faecium affects appendicular skeletal muscle mass, calf circumference, handgrip strength, and BMI via Shikimic acid metabolites. This study elucidates the potential mechanisms by which the gut microbiome influences the progress of sarcopenia through metabolites and provides a meaningful theoretical foundation for reference in the diagnosis and treatment of sarcopenia.

Mass Spectrometry-Based Multiomics Identifies Metabolic Signatures of Sarcopenia in Rhesus Monkey Skeletal Muscle

Integrated Multi-Omics Analysis Identifies Disrupted Branched-Chain Amino Acid Catabolism As Causal for Sarcopenia

Multi-omics Research in Sarcopenia: Current Progress and Future Prospects

Characterization of the Skeletal Muscle Proteome in Undernourished Old Rats

Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and health span in C. elegans

Reduced energy metabolism contributing to aging of skeletal muscle by serum metabolomics and gut microbiota analysis

Automated rodent in situ muscle contraction assay and myofiber organization analysis in sarcopenia animal models.

Single nuclei profiling identifies cell specific markers of skeletal muscle aging, sarcopenia and senescence

The Effect of Metabolites on Mitochondrial Functions in the Pathogenesis of Skeletal Muscle Aging

Metabolic signatures and risk of sarcopenia in suburb-dwelling older individuals by LC-MS–based untargeted metabonomics

Multiomics mapping and characterization of cellular senescence in aging human skeletal muscle uncovers a novel senotherapeutic for sarcopenia

Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing

Mitochondrial Quantity and Quality in Age-Related Sarcopenia

An Integrated Analysis of Metagenomics and Targeted and Untargeted Metabolomics of Skeletal Muscle Mass Adjusted for BMI among Chinese Peri-/Post-Menopausal Women

Identification of nicotinamide N‐methyltransferase as a promising therapeutic target for sarcopenia

Metabolites of the gut microbiota may serve as precise diagnostic markers for sarcopenia in the elderly

The Neuromuscular Junction is a Focal Point of Mtorc1 Signaling in Sarcopenia

Metabolome-wide Mendelian Randomization Assessing the Causal Relationship between Blood Metabolites and Sarcopenia-related Traits

Current understanding of sarcopenia: possible candidates modulating muscle mass

Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia.

Cross-Species Studies Reveal That Dysregulated Mitochondrial Gene Expression and Electron Transport Complex I Activity Are Crucial for Sarcopenia